Gene Proliferation Signature and Colon Cancer
Author Information
Author(s): Anjomshoaa A, Lin Y-H, Black M A, McCall J L, Humar B, Song S, Fukuzawa R, Yoon H-S, Holzmann B, Friederichs J, van Rij A, Thompson-Fawcett M, Reeve A E
Primary Institution: University of Otago, Dunedin, New Zealand
Hypothesis
Is there an association between gene proliferation signature expression and malignancy in colon cancer?
Conclusion
Reduced expression of a gene proliferation signature is linked to a higher likelihood of recurrence and shorter disease-free survival in colon cancer patients.
Supporting Evidence
- Reduced GPS expression was significantly associated with higher disease stage.
- Patients with reduced GPS expression had shorter disease-free survival.
- Validation of the GPS was performed using public breast cancer data.
Takeaway
This study found that colon cancer tumors with lower levels of a specific gene signature are more likely to come back after treatment, which is surprising because we usually think faster-growing tumors are worse.
Methodology
The study used gene expression profiling and K-means clustering to analyze two cohorts of colon cancer patients and their tumor samples.
Potential Biases
The study claims to have minimized bias by validating findings with public breast cancer data.
Limitations
The study did not include patients with rectal cancer or those who received pre-operative adjuvant therapy.
Participant Demographics
Cohort A included 108 New Zealand patients and Cohort B included 37 German patients, with a mix of disease stages.
Statistical Information
P-Value
0.021 and 0.005 for cohorts A and B respectively
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website